Allogene Therapeutics
ALLO
#8751
Rank
โ‚น20.15 B
Marketcap
โ‚น58.16
Share price
-5.88%
Change (1 day)
-47.22%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): -โ‚น61.31

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น62.08. In 2025 the company made an earnings per share (EPS) of -โ‚น80.61 an increase over its 2024 EPS that were of -โ‚น123.24.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น61.31-23.95%
2025-โ‚น80.61-34.59%
2024-โ‚น123.24
2022-โ‚น214.9722.75%
2021-โ‚น175.13-9.13%
2020-โ‚น192.7314.92%
2019-โ‚น167.71-9.42%
2018-โ‚น185.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA